All companies, by net margin
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net margin | Quarter |
|---|---|---|---|---|---|
| Not ranked below this line: we do not hold four quarters in a row, or a quarter's bottom line is withheld because the filing's copy of it cannot be trusted, so the figure is not the same quantity as the ones above it. | |||||
| – |
|
$16.8B | $124.29 −2.1% | 9% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 DD DuPont |
| – |
|
$39.0B | $139.41 +1.1% | 9% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 DHI D. R. Horton |
| – |
|
$61.8B | $61.78 +0.5% | 9% 3 of four quarters in a row 2025: Q2, Q3, Q4 | Q4 FY25 OXY Occidental Petroleum |
| – |
|
$16.0B | $22.23 +0.8% | 9% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 WY Weyerhaeuser |
| – |
|
$13.6B | $115.03 −2.1% | 8% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 ALB Albemarle |
| – |
|
$13.0B | $170.92 +0.9% | 8% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 AVY Avery Dennison |
| – |
|
$39.8B | $490.18 +2.3% | 8% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 AXON Axon Enterprise |
| – |
|
$48.4B | $103.64 −1.6% | 8% 1 of four quarters in a row 2025: Q4 | Q4 FY25 ETR Entergy |
| – |
|
$19.5B | $36.47 +1.7% | 8% 2 of four quarters in a row 2026: Q2, Q3 | Q3 FY26 GIS General Mills |
| – |
|
$10.2B | $173.25 −0.9% | 8% 1 of four quarters in a row 2026: Q1 | Q1 FY26 UHS Universal Health Services |
| – |
|
$6.9B | $39.08 +0.4% | 7% 1 of four quarters in a row 2026: Q2 | Q2 FY26 TAP Molson Coors Beverage |
| – |
|
$55.3B | $13.86 −0.8% | 6% 1 of four quarters in a row 2026: Q1 | Q1 FY26 F Ford Motor |
| – |
|
$55.0B | $37.05 +0.7% | 6% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 NKE Nike |
| – |
|
$22.2B | $81.07 +2.6% | 6% 1 of four quarters in a row 2026: Q1 | Q1 FY26 OMC Omnicom |
| – |
|
$13.4B | $88.89 −0.4% | 5% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 SWK Stanley Black & Decker |
| – |
|
$12.8B | $31.52 +3.5% | 4% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CSGP CoStar |
| – |
|
$76.5B | $87.16 +1.8% | 4% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 GM General Motors |
| – |
|
$40.4B | $171.49 +0.8% | 4% 1 of four quarters in a row 2026: Q2 | Q2 FY26 LYV Live Nation Entertainment |
| – |
|
$41.7B | $86.44 −0.3% | 3% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 ADM Archer Daniels Midland |
| – |
|
$34.3B | $69.41 +4.5% | 3% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 CNC Centene |
| – |
|
$122B | $95.55 +0.9% | 3% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| – |
|
$92.0B | $424.24 +1.3% | 3% 1 of four quarters in a row 2026: Q2 | Q2 FY26 ELV Elevance Health |
| – |
|
$18.4B | $133.21 −0.4% | 3% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 GPC Genuine Parts |
| – | HUM S&P 500 Humana S&P 500 Share price: $407.02 −0.7% Q1 FY26 HUM Humana | $48.9B | $407.02 −0.7% | 3% 1 of four quarters in a row 2026: Q1 | Q1 FY26 HUM Humana |
| – |
|
$15.3B | $89.82 +2.7% | 3% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 SOLV Solventum |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.